Society
**Maximizing R&D: The Inflation Reduction Acts Impact on Prescription Drug Prices**
The Inflation Reduction Act allows the federal government to negotiate drug prices with Medicare, improving benefits and limiting price increases. It generates debate about the impact on innovation, with possible increases in post-IRA R&D activity, according to research. Authors: Richard G. Frank and Ben Graham.
September 12, 2025